Fasnall T27307
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Fasnall is a selective FASN inhibitor that acts through its co-factor binding sites. Fasnall shows potent anti-tumor activity in the MMTV-Neu model of HER2(+) breast cancer, particularly when combined with carboplatin.
CAS nr:
929978-58-5
Purity:
98%
Molecular Weight:
510,67
SMILES:
CC1=C(C)C2=C(NC3CN(CC4=CC=CC=C4)CC3)N=CN=C2S1.OS(=O)(C5=CC=C(C)C=C5)=O
Formula:
C26H30N4O3S2
Pathway:
Metabolism
Target:
Fatty Acid Synthase
